Published in Gene Therapy Weekly, March 31st, 2005
Genzyme is also seeking to add the ablation indication to the product's U.S. label and expects regulatory action on its submission in the second half of this year. Approximately 35,000 ablation procedures are performed annually in the United...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.